CMS Releases 2026 Medicare Physician Fee Schedule Final Rule
CMS released the 2026 MPFS final rule Oct. 31. ACR prepared an initial summary about impact on imaging.
Read moreMain Content
ACR Congratulates Sirtex Medical on FDA Approval of Its SIR-Spheres to Treat Liver Cancer
The ACR-managed clinical trial was a key part of the approval effort.
Aug. 6, 2025
The ACR® Center for Research and Innovation (CRI®) served as the imaging contract research organization for the DOORwaY90 clinical trial that contributed to FDA approval of Sirtex SIR-Spheres technology for liver cancer treatment.
CRI’s management of image and data collection, quality control, and central review of 600 CT/MRI scans from 65 subjects across 12 sites using five expert reviewers was critical to the success of the trial.
Interim analysis of the DOORwaY90 trial revealed that 98.5% of patients had the Best Overall Response Rate through nine months and 100% of all evaluable patients were able to demonstrate local tumor control.
Related ACR News
Massachusetts Legislature Updates Prior Authorization Bill
Massachusetts HB 4616 aims to streamline prior authorization, boost transparency, and study its impact on care access and costs.
Read moreACR Responds to RFI on AI Regulatory Reform
ACR urged the White House to enhance AI oversight and payment policies to support safe, effective, and reimbursable clinical AI use.
Read more